Elmind Capital, LP

NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$403.8M2026 Q3
Positions30
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.65.1%

Elmind Capital, LP reported 30 positions worth $403.8M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: CLDX (8.9%). Biggest move: add AMLX ($22.8M).

10 / 30 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 CLDXCelldex Therapeutics$36.0M8.91%1,110,000———
▸ 2 LEGNLegend Biotech$31.2M7.73%1,569,676——-12.0%
▸ 3 SNDXSyndax Pharmaceuticals$30.2M7.47%1,605,000——-49.7%
▸ 4 COGTCogent Biosciences$27.8M6.87%866,742——-10.8%
▸ 5 RLAYRelay Therapeutics$26.4M6.55%1,465,279——-4.3%
▸ 6 AMLXAmylyx Pharmaceuticals$26.0M6.45%894,760——-4.5%
▸ 7 VRDNViridian Therapeutics$25.2M6.25%1,224,931——+49.9%
▸ 8 PCVXVaxcyte$21.2M5.25%372,340——+8.3%
▸ 9 URGNUroGen Pharma$20.0M4.94%491,100——-30.8%
▸ 10 TVTXTravere Therapeutics$19.0M4.70%322,600——-15.6%

Pro Feature

The remaining 20 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Elmind Capital, LP hold as of Q3 2026?

Elmind Capital, LP reported 30 positions worth $403.8M in its Q3 2026 13F filing. Largest positions: CLDX (8.9%), LEGN (7.7%), SNDX (7.5%), COGT (6.9%) and RLAY (6.5%).

What did Elmind Capital, LP buy in Q3 2026?

Added to: AMLX, LEGN, URGN, IMCR and VRDN (11 in all).

What did Elmind Capital, LP sell in Q3 2026?

Reduced: COGT, SNDX, PCVX, PHVS and MBX. Sold out entirely: INSM, PTGX, 96663EUR, TYRA and ENGN.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.